TY - JOUR
T1 - Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis
AU - Suppa, Antonio
AU - Asci, Francesco
AU - Costantini, Giovanni
AU - Bove, Francesco
AU - Piano, Carla
AU - Pistoia, Francesca
AU - Cerroni, Rocco
AU - Brusa, Livia
AU - Cesarini, Valerio
AU - Pietracupa, Sara
AU - Modugno, Nicola
AU - Zampogna, Alessandro
AU - Sucapane, Patrizia
AU - Pierantozzi, Mariangela
AU - Tufo, Tommaso
AU - Pisani, Antonio
AU - Peppe, Antonella
AU - Stefani, Alessandro
AU - Calabresi, Paolo
AU - Bentivoglio, Anna Rita
AU - Saggio, Giovanni
AU - Daniele, Antonio
AU - group, Lazio DBS study
PY - 2023
Y1 - 2023
N2 - Introduction: Deep brain stimulation of the subthalamic nucleus (STN-DBS) can exert relevant effects on the voice of patients with Parkinson's disease (PD). In this study, we used artificial intelligence to objectively analyze the voices of PD patients with STN-DBS.Materials and methods: In a cross-sectional study, we enrolled 108 controls and 101 patients with PD. The cohort of PD was divided into two groups: the first group included 50 patients with STN-DBS, and the second group included 51 patients receiving the best medical treatment. The voices were clinically evaluated using the Unified Parkinson's Disease Rating Scale part-III subitem for voice (UPDRS-III-v). We recorded and then analyzed voices using specific machine-learning algorithms. The likelihood ratio (LR) was also calculated as an objective measure for clinical-instrumental correlations.Results: Clinically, voice impairment was greater in STN-DBS patients than in those who received oral treatment. Using machine learning, we objectively and accurately distinguished between the voices of STN-DBS patients and those under oral treatments. We also found significant clinical-instrumental correlations since the greater the LRs, the higher the UPDRS-III-v scores.Discussion: STN-DBS deteriorates speech in patients with PD, as objectively demonstrated by machine-learning voice analysis.
AB - Introduction: Deep brain stimulation of the subthalamic nucleus (STN-DBS) can exert relevant effects on the voice of patients with Parkinson's disease (PD). In this study, we used artificial intelligence to objectively analyze the voices of PD patients with STN-DBS.Materials and methods: In a cross-sectional study, we enrolled 108 controls and 101 patients with PD. The cohort of PD was divided into two groups: the first group included 50 patients with STN-DBS, and the second group included 51 patients receiving the best medical treatment. The voices were clinically evaluated using the Unified Parkinson's Disease Rating Scale part-III subitem for voice (UPDRS-III-v). We recorded and then analyzed voices using specific machine-learning algorithms. The likelihood ratio (LR) was also calculated as an objective measure for clinical-instrumental correlations.Results: Clinically, voice impairment was greater in STN-DBS patients than in those who received oral treatment. Using machine learning, we objectively and accurately distinguished between the voices of STN-DBS patients and those under oral treatments. We also found significant clinical-instrumental correlations since the greater the LRs, the higher the UPDRS-III-v scores.Discussion: STN-DBS deteriorates speech in patients with PD, as objectively demonstrated by machine-learning voice analysis.
KW - Parkinson's disease
KW - deep brain stimulation
KW - machine-learning
KW - subthalamic nucleus
KW - voice analysis
KW - Parkinson's disease
KW - deep brain stimulation
KW - machine-learning
KW - subthalamic nucleus
KW - voice analysis
UR - https://publicatt.unicatt.it/handle/10807/258049
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85175874867&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85175874867&origin=inward
U2 - 10.3389/fneur.2023.1267360
DO - 10.3389/fneur.2023.1267360
M3 - Article
SN - 1664-2295
VL - 14
SP - N/A-N/A
JO - Frontiers in Neurology
JF - Frontiers in Neurology
IS - 19
ER -